Lowell Farms Inc (LOWLF) Fair Value & Analysis
Healthcare · US · Market cap $1.8K
Lowell Farms Inc
LOWLF · US
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $2.85 to $0.0001 (−100.0%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0001 – $0.0175 · the $0.0001 price screens below the $0.0001 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Lowell Farms Inc (LOWLF) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 26/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Trailing-twelve-month revenue stands at $19.2M. Revenue declined 47.8% year over year. Net debt stands at $15.2M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Lowell Farms Inc. engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California. The company provides flowers, vape pens, oils, extracts, chocolate edibles, mints, gummies, topicals, tinctures, and pre-rolls under the House Weed, Moon, Original Pot Company, Cypress Cannabis, Humble Flower, Flavor Extracts, and Kaizen. It also manufactures and distributes premium packaged flowers, pre-rolls, concentrates, and vape products under the Lowell Herb Co. and Lowell Smokes brands; and automated pre-rolls under the 35s brand, as well as products for several other third party brands. In addition, the company provides manufacturing, extraction processing, and distribution services to third-party cannabis and cannabis branding companies; and bulk extraction concentrates and flowers to licensed manufacturers and distributors. The company was formerly known as Indus Holdings, Inc. and …
Revenue & earnings trend
FY2019 – FY2023 · reported fiscal years
Lowell Farms Inc reported revenue of $28.3M in FY2023 versus $37.0M in FY2019, a compound −6.5%/yr. Reported net income was −$37.3M in FY2023.
Is LOWLF fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,863 | ₹1,039 | -44% |
| Zoetis Inc Z1TS34 | R$24.45 | R$6.33 | -74% |
| Hansoh Pharmaceutical Group 3692 | HK$29.58 | HK$18.75 | -37% |
| Divi's Laboratories Limited DIVISLAB | ₹6,788 | ₹2,035 | -70% |
| Swedish Orphan Biovitrum AB SOBI | kr 444.80 | kr 440.64 | -1% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Lowell Farms Inc (LOWLF) undervalued?
What is the fair value of LOWLF?
What is the quality score of LOWLF?
What is the revenue of Lowell Farms Inc (LOWLF)?
What is the net profit margin of LOWLF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.